Cancer Research Society and Ovarian Cancer Canada: Bridging the Gap for Ovarian Cancer Treatments
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $600,000 over three years.
Disciplines:
- Health Sciences
Sponsors:
- Cancer Research Society
Deadlines:
Internal Deadline:
January 3, 2024Sponsor Deadline:
April 10, 2024Additional Dates:
- LOI HRS Due Date - January 3, 2024
- LOI Sponsor Due Date - January 17, 2024
- Application Sponsor Due Date (by invitation) - April 10, 2024
Description:
This opportunity supports clinical/translational research projects which will contribute to improving precision oncology in ovarian cancer. Treatments which may benefit women diagnosed with less common types of ovarian cancer (e.g. endometrioid, clear cell, low-grade serous, mucinous or non-epithelial) are encouraged.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.